Wellbutrin is not a tricyclic antidepressant. Its FDA-approved prescribing information states explicitly that bupropion hydrochloride, the active ingredient in Wellbutrin, is “chemically unrelated to tricyclic, tetracyclic, selective serotonin re-uptake inhibitor, or other known antidepressant agents.” Wellbutrin belongs to a completely different drug class called aminoketones, and it works through a distinct mechanism that sets it apart from tricyclics in both its effects and its side effect profile.
How Wellbutrin Is Classified
Wellbutrin is categorized as a second-generation aminoketone antidepressant. You’ll also see it labeled as an “atypical antidepressant” or an NDRI (norepinephrine-dopamine reuptake inhibitor), which describes what it does in the brain rather than its chemical family. It was originally designed and marketed as an atypical antidepressant, and the same active ingredient later became the basis for Zyban, a smoking cessation medication licensed in the U.S. in 1998.
Tricyclic antidepressants, by contrast, are an older class of drugs named for their three-ring chemical structure. Common tricyclics include amitriptyline, nortriptyline, and clomipramine. Wellbutrin’s chemical structure is a single-ring compound (monocyclic), which is fundamentally different from the three-ring backbone that defines the tricyclic class.
Why the Mechanism Matters
The biggest practical difference between Wellbutrin and tricyclics is which brain chemicals they target and how broadly they act. Wellbutrin works by blocking the reuptake of two neurotransmitters: dopamine and norepinephrine. It has slightly stronger activity at the dopamine transporter than the norepinephrine transporter, and its effect on serotonin is negligible even at high concentrations. Brain levels of bupropion and its active byproducts stay above the threshold needed to block dopamine and norepinephrine reuptake throughout a standard 12-hour dosing window.
Tricyclic antidepressants also block norepinephrine reuptake, but most of them have significant effects on serotonin as well. More importantly, tricyclics bind to a range of other receptors in the body, including histamine receptors, acetylcholine receptors, and certain heart-related receptors. That broad activity is the reason tricyclics carry a heavier burden of side effects. Wellbutrin has no clinically meaningful direct effects on these postsynaptic receptors, which gives it a much cleaner side effect profile in several key areas.
Side Effects Compared to Tricyclics
The side effects that bother people most about older antidepressants, particularly tricyclics, tend to fall into a few categories: weight gain, sexual problems, sedation, and dry mouth or constipation from anticholinergic activity. Wellbutrin differs from tricyclics on nearly all of these.
Sexual side effects are one of the clearest contrasts. Wellbutrin has one of the lowest rates of sexual dysfunction among all antidepressants. Tricyclics, on the other hand, are more likely to cause problems in this area, with clomipramine carrying the highest risk in that class. For people who have experienced sexual side effects on other antidepressants, this distinction is often the reason their doctor considers switching to bupropion.
Weight is another area where the two diverge. Tricyclics are well known for causing weight gain, largely because of their activity on histamine receptors. Wellbutrin is considered weight-neutral or even associated with modest weight loss in some people, since it doesn’t bind meaningfully to histamine receptors. Sedation follows the same pattern: tricyclics tend to cause drowsiness, while bupropion is mildly stimulating for most people.
Wellbutrin does carry its own set of side effects. The most notable risk is a dose-dependent increase in seizure likelihood, which is why it has a maximum daily dose ceiling. Insomnia, dry mouth, and agitation are also common. But the overall profile looks very different from what you’d expect with a tricyclic.
What Wellbutrin Is Approved to Treat
Wellbutrin is FDA-approved for the treatment of major depressive disorder. The extended-release formulation (Wellbutrin XL) also has approval for preventing seasonal affective disorder. While Wellbutrin itself is not approved for smoking cessation, the same active ingredient is sold under the brand name Zyban specifically for that purpose.
Tricyclics, by comparison, are approved for depression but are also frequently used for chronic pain conditions, migraines, and certain anxiety disorders. The two drug classes are not interchangeable, and a prescription for one would not typically be swapped for the other without a specific clinical reason, since they act on different neurotransmitter systems and produce different therapeutic effects.
Why People Confuse the Two
The confusion likely stems from the fact that both Wellbutrin and tricyclics are antidepressants, and many people group all antidepressants together. The major antidepressant classes include SSRIs, SNRIs, tricyclics, MAOIs, and atypicals. Wellbutrin falls into the atypical category, which is essentially a catch-all for antidepressants that don’t fit neatly into the other groups. Its unique chemistry, a monocyclic aminoketone with selective dopamine and norepinephrine activity, places it in a class of its own rather than alongside the older tricyclic drugs.